Search

everythinglearnresearchcommunity

for

Search:↓

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

Reflectance confocal microscopy can tell apart white dots on the scalp as either sweat gland ducts or hair follicle openings.

Monitoring for adverse effects in clinical treatments is crucial.

A stable and simple finasteride suspension was developed that retains over 94.3% of its concentration for up to 90 days and doesn't significantly increase occupational exposure, but safety measures are still advised.

High-dose finasteride may help treat glioblastoma but needs localized delivery for effectiveness.

Eclipta alba phytosomes improve bioavailability and therapeutic effects.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Wnt7a protein is crucial for development and tissue maintenance and plays varying roles in diseases and potential treatments.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Targeting lipid metabolism can help treat advanced, resistant cancers.

DNA methylation controls lncRNA2919, which negatively affects hair growth.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

Innovative methods are reducing animal testing and improving biomedical research.

A mutation in the KRT71 gene causes a hair disorder by disrupting hair follicle structure and texture.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

Sodium metabisulfite increases sodium channel activity, leading to higher cell excitability and potential damage.